Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Koschinsky

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Current Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disordersM B Boffa, M E Nesheim, M L Koschinsky
Kidney International|May 15, 2007
Evidence mounts for a role of the kidney in lipoprotein(a) catabolismJ J Albers, M L Koschinsky, S M Marcovina
Biochemistry|April 18, 1995
Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activationW Sangrar, L Bajzar, M E Nesheim, et al.
Protein Engineering|July 31, 2001
Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen bindingM N Rahman, V Petrounevitch, Z Jia, et al.
Protein Science : a Publication of the Protein Society|May 23, 2001
High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand bindingQ Ye, M N Rahman, M L Koschinsky, et al.
Canadian Journal of Physiology and Pharmacology|March 1, 1994
Analysis of structure--function relationships in human apolipoprotein(a)Y Y van der Hoek, J J Kastelein, M L Koschinsky
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Sequences within the amino terminus of ApoB100 mediate its noncovalent association with apo(a)B R Gabel, R S McLeod, Z Yao, et al.
Clinical Genetics|March 31, 1998
Analysis of the mechanism of lipoprotein(a) assemblyM L Koschinsky, S M Marcovina, L F May, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activationN T Feric, M B Boffa, S M Johnston, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1996
Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formationB R Gabel, L F May, S M Marcovina, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Current Drug Targets. Cardiovascular & Haematological Disorders|May 29, 2003
Thrombin activable fibrinolysis inhibitor (TAFI): molecular genetics of an emerging potential risk factor for thrombotic disordersM B Boffa, M E Nesheim, M L Koschinsky
Kidney International|May 15, 2007
Evidence mounts for a role of the kidney in lipoprotein(a) catabolismJ J Albers, M L Koschinsky, S M Marcovina
Biochemistry|April 18, 1995
Antifibrinolytic effect of recombinant apolipoprotein(a) in vitro is primarily due to attenuation of tPA-mediated Glu-plasminogen activationW Sangrar, L Bajzar, M E Nesheim, et al.
Protein Engineering|July 31, 2001
Antifibrinolytic effect of single apo(a) kringle domains: relationship to fibrinogen bindingM N Rahman, V Petrounevitch, Z Jia, et al.
Protein Science : a Publication of the Protein Society|May 23, 2001
High-resolution crystal structure of apolipoprotein(a) kringle IV type 7: insights into ligand bindingQ Ye, M N Rahman, M L Koschinsky, et al.
Canadian Journal of Physiology and Pharmacology|March 1, 1994
Analysis of structure--function relationships in human apolipoprotein(a)Y Y van der Hoek, J J Kastelein, M L Koschinsky
Arteriosclerosis, Thrombosis, and Vascular Biology|November 13, 1998
Sequences within the amino terminus of ApoB100 mediate its noncovalent association with apo(a)B R Gabel, R S McLeod, Z Yao, et al.
Clinical Genetics|March 31, 1998
Analysis of the mechanism of lipoprotein(a) assemblyM L Koschinsky, S M Marcovina, L F May, et al.
Journal of Thrombosis and Haemostasis : JTH|November 6, 2008
Apolipoprotein(a) inhibits the conversion of Glu-plasminogen to Lys-plasminogen: a novel mechanism for lipoprotein(a)-mediated inhibition of plasminogen activationN T Feric, M B Boffa, S M Johnston, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1996
Lipoprotein(a) assembly. Quantitative assessment of the role of apo(a) kringle IV types 2-10 in particle formationB R Gabel, L F May, S M Marcovina, et al.
Pageof 6